I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| erythroblast | 5 studies | 38% ± 15% | |
| plasmablast | 4 studies | 31% ± 17% | |
| hematopoietic precursor cell | 4 studies | 20% ± 3% | |
| pro-B cell | 4 studies | 26% ± 7% | |
| megakaryocyte-erythroid progenitor cell | 4 studies | 32% ± 15% | |
| B cell | 3 studies | 22% ± 3% | |
| erythrocyte | 3 studies | 39% ± 14% | |
| transit amplifying cell | 3 studies | 39% ± 22% | |
| precursor B cell | 3 studies | 33% ± 2% | |
| natural killer cell | 3 studies | 32% ± 10% | |
| CD8-positive, alpha-beta T cell | 3 studies | 26% ± 5% | |
| T cell | 3 studies | 22% ± 4% |
